For new knee inflammatory arthritis nearly 60% are in full remission at one year whereas 10% spread to progressive arthritis and 30% have persistent knee IA. Leiden Early arthritis cohort #EULAR2019 @RheumNow https://t.co/ZuLI1OCfhT https://t.co/x2Tr1tF0j6

• Janet Pope on Twitter: "What happens to momo or bilateral knee synovitis i…

Poster THU0687 FMF and schizo each increase mortality and worse if co-occurrence #EULAR2019 @RheumNow https://t.co/nVfiw25Lzf https://t.co/U9KELLJzVD

• Janet Pope on Twitter: "Strange lack of association Schizophrenia is decre…

Be sure not to miss our symposium tomorrow morning: ‘The Patient Perspective: Addressing Challenges Facing Women with #axSpA and PsA’. Join us tomorrow! #EULAR2019 #psoriaticarthritis https://t.co/G0NkmblAhI

Checkpoint inhibitor use is exploding in cancer Rx. Big data review of 13000 cases of immune mediated reactions are mostly endo, GI and pulmonary and NOT rheumatic THUS0628 #EULAR2019 @RheumNow https://t.co/iYO8t6ALBx

Olofsson, Sweden: important topic of unacceptable residual pain despite biologic in PsA with >80% of this pain despite good inflammatory control #Eular2019 @RheumNow https://t.co/vjiakjCKR0

What happens to momo or bilateral knee synovitis in 12 months? #EULAR2019 @RheumNow THU0674

Strange lack of association Schizophrenia is decreased in Familial Med fever (FMF). HLA B08 is protective against schizo in RA. They speculate that pure autoimmune diseases have more schizo and auto inflammatory less schizo #EULAR2019 @RheumNow

Great clinical advice from @MarieKostine in today's EULAR recommendations on rheumatic irAEs from cancer immunotherapy, but most of all, oncologists should be encouraged to refer promptly and rheumatologists need to make themselves readily accessible! #EULAR2019 OP0165 @RheumNow

Immune mediated reactions from checkpoint inhibitors mostly are rheumatologic. THU0628 #EULAR2019 @RheumNow

Come see our poster THU0689- asthma and elevation of ACPA prior to RA onset. Women with asthma had 4-fold increased risk pre-RA ACPA+ a mean of 8 years prior to RA dx. Supports mucosal hypothesis where inflamed airways promote ACPA genesis #EULAR19 https://t.co/zivVinwEWS

Giant cell arteritis 42% with clinical remission and no treatment after 1 year of weekly #Tocilizumab... remission after 2 years.. Dr. John H. Stone https://t.co/WqvGLxBLQA

ANCA #VASCULITIS 👉🏻A maintenance treatment should be prescribed 👉🏻Anti-PR3 patients > MPO 👉🏻Rituximab is the best drug to maintain remission 👉🏻Some patients could deserve a"very long term maintenance treatment",may be all life 👉🏻A specific approach is needed in EGPA #EULAR2019 https://t.co/s3JlUahN4m

Flares: well, I had hoped for more from that top highlighted line. What is going to happen to our real-life patients who have had a year of TCZ and then come off? https://t.co/QvsEfYpahi

From there, we’re looking at clinical clinician choice. So what happened when TCZ stopped? https://t.co/HJl0VJuN8p

Riociquat studied in early PSS w/ mRSS 10–22 and showed a trend to decrease mRSS (p=0.08) & no effect on lungs. But subanalysis of SSc-ILD showed significant improvements in FVC. #EULAR19 OP0183 https://t.co/fP6snUHU1r